Coronary Artery Bypass Graft Surgery After Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction.

Heart Lung Circ

Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address:

Published: October 2023

AI Article Synopsis

  • The study aimed to assess if primary percutaneous coronary intervention (PPCI) increases adverse outcomes after coronary artery bypass graft (CABG) in patients with ST-elevation myocardial infarction (STEMI).
  • Out of 354 STEMI patients who had CABG, 222 had undergone PPCI; the outcomes for both groups were compared regarding in-hospital mortality, length of stay, and bleeding events.
  • Results showed that PPCI did not significantly affect overall in-hospital mortality, length of stay, or bleeding incidents, though patients with complicated PPCIs showed a higher mortality risk compared to those who only had CABG.

Article Abstract

Objective: To determine whether primary percutaneous coronary intervention (PPCI) is associated with adverse outcomes following coronary artery bypass graft (CABG) among patients with ST-elevation myocardial infarction (STEMI).

Methods: Patients presenting with acute STEMI who underwent CABG between September 2015 and November 2020 were included. Among 354 patients, 222 (62.7%) underwent PPCI prior to CABG (PPCI+CABG group) and were compared with the rest of the patients (CABG only group). The effects of PPCI on primary endpoints---including in-hospital mortality, length of stay (LOS), and bleeding events---were investigated using the stabilised inverse probability weighting method (S-IPW). Further, in-hospital mortality in various PPCI subgroups was analysed using univariable regression.

Results: Patients with and without PPCI were comparable regarding their baseline and surgical characteristics, except that those without PPCI were more likely to have left-main disease (29.5% vs 16.2%, p-value=0.003). Among the PPCI+CABG group, 3.6% mortality and 55.9% bleeding events occurred, and the LOS was 7 [5-10] days. The respective figures for the CABG only group were 4.5%, 50.8%, and 7 [6-10.5] days. Primary percutaneous coronary intervention, as a whole, was not significantly associated with either morality (S-IPW odds ratio (S-IPW OR) 0.61; p=0.393), LOS logarithm (S-IPW β -0.050; p=0.403), or bleeding events (S-IPW OR 1.06; p=0.821). Nevertheless, the unadjusted mortality risk was significantly higher in complicated PPCIs compared with the CABG only group (OR 7.50, 95% CI 2.03-27.77); it was also higher among some other PPCI subgroups, albeit non-significantly.

Conclusion: This study found that PPCI did not confer additional risk regarding in-hospital mortality, LOS, or bleeding among patients with acute STEMI who underwent CABG. However, some PPCI subgroups, especially those with complicated PPCI, were at increased risk.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hlc.2023.08.005DOI Listing

Publication Analysis

Top Keywords

primary percutaneous
12
percutaneous coronary
12
coronary intervention
12
cabg group
12
in-hospital mortality
12
ppci subgroups
12
ppci
10
coronary artery
8
artery bypass
8
bypass graft
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!